Severe lichenified skin rash associated with apalutamide administration

QR Code

Severe lichenified skin rash associated with apalutamide administration

Saved in:

Bibliographic Details
Main Authors:	Chisato Watanabe, Shujiro Hayashi, Shown Tokoro, Ken Igawa
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Journal of Cutaneous Immunology and Allergy
Subjects:	adverse drug reaction lichenified skin rash apalutamide drug eruption prostate cancer
Online Access:	https://www.frontierspartnerships.org/articles/10.3389/jcia.2025.14936/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Capivasertib-induced polymorphous lichenoid exanthem: Report of a novel AKT kinase inhibitor-related drug eruption
by: Raj P. Fadadu, MD, MS, et al.
Published: (2025-08-01)

Association between efficacy and skin rash following treatment with the lapatinib in metastatic breast cancer
by: Suleyman Temiz, et al.
Published: (2016-04-01)

Skin rash along with pulmonary involvement: A case report
by: Pradipta Bhattacharjee
Published: (2025-01-01)

Rash and edema shortly after initial exposure to low dose cenobamate
by: Christopher Saouda, et al.
Published: (2025-09-01)

Acneiform rash — skin toxic reaction to the use of EGFR inhibitors
by: E. A. Shatokhina, et al.
Published: (2019-01-01)

Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and an algorithm for acne-like rash correction
by: A. V. Michenko, et al.
Published: (2021-11-01)

Drug reactions with skin manifestations. How to discover?
by: Yu. G. Haliulin, et al.
Published: (2021-06-01)

Drug reactions with skin manifestations. How to discover?
by: Yu. G. Haliulin, et al.
Published: (2021-06-01)

Bullous fixed drug eruption due to erlotinib: A rare case report
by: Kallolinee Samal, et al.
Published: (2025-07-01)

Flagellate Rash in Chikungunya: A Comprehensive Review of Dermatological Manifestations
by: Nikhil Mehta, et al.
Published: (2025-07-01)

Reactive Infectious Mucocutaneous Eruption (RIME): Narrative Review and Proposed Management Algorithm
by: Víctor García Rodríguez, et al.
Published: (2025-07-01)

Clinical Features of Drug Eruption in An Indonesian Tertiary Hospital
by: Enny Rohmawaty, et al.
Published: (2025-03-01)

Fixed drug eruption caused by fluconazole
by: T. N. Myasnikova, et al.
Published: (2023-12-01)

Giving Olive Oil to Diaper Rash in Infants Aged 6-12 Months in The Work Area Of The Nambo Health Center
by: Suhartati Suhartati, et al.
Published: (2023-05-01)

INVESTIGATION OF MEDICALLY INDUCED SKIN REACTIONS BASED ON THE ANALYSIS OF REPORTS OF ADVERSE DRUG REACTIONS IN THE REPUBLIC OF CRIMEA (FROM 2009 TO 2016)
by: A. V. Matveev, et al.
Published: (2019-03-01)

Case Report: Mycoplasma pneumoniae-induced rash and mucositis in a child
by: Xiaoying Mo, et al.
Published: (2025-07-01)

A case of acute generalized exanthematous pustulosis following administration of nemolizumab
by: Alyssa Khoo, BA, et al.
Published: (2025-08-01)

A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
by: Toshiki Okazaki, MD, et al.
Published: (2025-09-01)

Advances in the diagnosis and treatment of atopic eruption in pregnancy
by: LIU Ping, et al.
Published: (2025-05-01)

Terbinafine-induced generalized pustular psoriasis treated with dapsone
by: Matilde Monteiro, et al.
Published: (2025-04-01)

ADVERSE DRUG REACTIONS IN CRIMEA REPUBLIC IN 2013
by: O. I. Koniaieva, et al.
Published: (2022-06-01)

Drug-induced toxicodermia as implication of a drug disease
by: O. L. Romanova
Published: (2015-09-01)

KNOWLEDGE, ATTITUDE AND PRACTICE AMONG HEALTHCARE PROFESSIONALS TOWARDS ADR REPORTING IN ABBOTTABAD PAKISTAN
Published: (2021-12-01)

Risks of Oral Methotrexate Administration in Outpatients
by: Maria Ganeva, et al.
Published: (2014-11-01)

Unveiling the dual-edged roles of melanocytes: Key insights into skin photoaging and therapeutic avenues
by: Xiaorong Jia, et al.
Published: (2025-08-01)

EVALUATIONS OF ADVERSE DRUGS REACTIONS IN RUSSIA IN 2013
by: V. A. Merkulov, et al.
Published: (2022-05-01)

Lyell syndrome in 72% of the body surface
by: José Augusto Pupio Reis, et al.
Published: (2020-06-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

Drug-Induced Neutropenia and Agranulocytosis
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
by: N. V. Verlan, et al.
Published: (2017-02-01)

S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report
by: Ryosuke Yamaga, et al.
Published: (2018-06-01)

Serious skin reaction induced by leflunomide in a patient with juvenilechronic arthritis
by: Y V Muravjov, et al.
Published: (2009-02-01)

The current state and prospects for the development of the Ukrainian market of veterinary drugs for the treatment of skin diseases
by: I. V. Bushuieva, et al.
Published: (2023-04-01)

Potential adverse events of fluoxetine: a real-world study based on the FAERS database
by: Xuezheng Gao, et al.
Published: (2025-07-01)

Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer
by: Mike Wenzel, et al.
Published: (2025-07-01)

Clinical and pharmacological monitoring of drug safety in pediatrics
by: N. V. Verlan, et al.
Published: (2016-05-01)

Role of Pharmacovigilance in Drug Safety Monitoring
by: Anju E. Paul, et al.
Published: (2025-07-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)